Font Size




Menu Style

Clinical guidance on the use of antiviral drugs

Evaluation and registration of antiviral agents is undertaken at a national level by local regulatory authorities.  There are no international regulations. A small number of countries have issued national guidance on the use of antiviral drugs for both the treatment and prophylaxis of influenza virus infection, and the World Health Organization has published global guidelines. Links to published guidance can be found below.

Published research: Review of European recommendations for antiviral use

A study by Stephenson et al reviewed recommendations for use of antivirals for treatment and prevention of seasonal influenza in countries of the European Union. The authors identified recommendations in eight EU countries and concluded that there were significant differences on antiviral use between countries, and recommended the development of Europe-wide guidance. 

Stephenson I, Clark TW, Pareek M (2008). Antiviral treatment and prevention of seasonal influenza: a comparative review of recommendations in the European Union. J Clin Virol. 2008 Jul;42(3):244-8.

Global guidance on the use of antiviral drugs

World Health Organization

National guidance on the use of antiviral drugs

United Kingdom – issued by the National Centre for Health and Clinical Excellence (NICE), and by the Health Protection Agency.

United States of America

The websites listed above are not under the control of isirv-AVG, and the AVG is not responsible for their content. These links do not serve as an endorsement by the AVG of any of the sites, they are provided solely for the convenience of our users.  

Please contact us with the details of any URL changes.